Skip to content

The effect of probiotic supplementation on breast milk aflatoxin M1

Evaluation of the effect of probiotic supplementation on aflatoxin M1 levels in breast milk

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200326046868N2
Enrollment
40
Registered
2020-09-21
Start date
2020-09-25
Completion date
Unknown
Last updated
2020-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aflatoxin contamination.

Interventions

Intervention 1: Intervention group: They will take 2 probiotic supplements daily (after lunch and dinner) for 1 month. It is worth mentioning that in this study, several species of probiotic supplemen

Sponsors

Abadan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 39 Years

Inclusion criteria

Inclusion criteria: Breastfeeding mothers with babies 2 to 4 months NO chronic diseases

Exclusion criteria

Exclusion criteria: non breastfeeding mother without babies 2 to 4 months mothers with chronic disease

Design outcomes

Primary

MeasureTime frame
The amount of aflatoxin M1 in breast milk. Timepoint: Measuring the amount of flatoxin in breast milk At the beginning of the study and then for 1 month according to the divided group, they will take 2 probiotic supplements or placebo (daily after lunch and dinner). After the intervention, the amount of aflatoxin in breast milk will be measured again. Method of measurement: At the beginning of the study, the milk sample will be prepared by the mother herself using a manual milking machine in a sterile plastic container of 10-15 ml. The collected milk samples will be immediately transferred to the laboratory in the cold chain and in the freezer at -20 ° C. C will be maintained until analysis. ELISA is used to measure aflatoxin M1.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactArmin Khaleghjo

Abadan University of Medical Sciences

drykhaleghjoo@gmail.com+98 61 5338 4004

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026